Literature DB >> 12641434

Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells.

Christopher A Reilly1, William J Ehlhardt, David A Jackson, Palaniappan Kulanthaivel, Abdul E Mutlib, Robert J Espina, David E Moody, Dennis J Crouch, Garold S Yost.   

Abstract

Capsaicin is a common dietary constituent and a popular homeopathic treatment for chronic pain. Exposure to capsaicin has been shown to cause various dose-dependent acute physiological responses including the sensation of burning and pain, respiratory depression, and death. In this study, the P450-dependent metabolism of capsaicin by recombinant P450 enzymes and hepatic and lung microsomes from various species, including humans, was determined. A combination of LC/MS, LC/MS/MS, and LC/NMR was used to identify several metabolites of capsaicin that were generated by aromatic (M5 and M7) and alkyl hydroxylation (M2 and M3), O-demethylation (M6), N- (M9) and alkyl dehydrogenation (M1 and M4), and an additional ring oxygenation of M9 (M8). Dehydrogenation of capsaicin was a novel metabolic pathway and produced unique macrocyclic, diene, and imide metabolites. Metabolism of capsaicin by microsomes was inhibited by the nonselective P450 inhibitor 1-aminobenzotriazole (1-ABT). Metabolism was catalyzed by CYP1A1, 1A2, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, and 3A4. Addition of GSH (2 mM) to microsomal incubations stimulated the metabolism of capsaicin and trapped several reactive electrophilic intermediates as their GSH adducts. These results suggested that reactive intermediates, which inactivated certain P450 enzymes, were produced during catalytic turnover. Comparison of the rate and types of metabolites produced from capsaicin and its analogue, nonivamide, demonstrated similar pathways in the P450-dependent metabolism of these two capsaicinoids. However, production of the dehydrogenated (M4), macrocyclic (M1), and omega-1-hydroxylated (M3) metabolites was not observed for nonivamide. These differences may be reflective of the mechanism of formation of these metabolites of capsaicin. The role of metabolism in the cytotoxicity of capsaicin and nonivamide was also assessed in cultured lung and liver cells. Lung cells were markedly more sensitive to cytotoxicity by capsaicin and nonivamide. Cytotoxicity was enhanced 5 and 40% for both compounds by 1-ABT in BEAS-2B and HepG2, respectively. These data suggested that metabolism of capsaicinoids by P450 in cells represented a detoxification mechanism (in contrast to bioactivation).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12641434     DOI: 10.1021/tx025599q

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  18 in total

Review 1.  Rearrangement reactions catalyzed by cytochrome P450s.

Authors:  Paul R Ortiz de Montellano; Sidney D Nelson
Journal:  Arch Biochem Biophys       Date:  2010-10-29       Impact factor: 4.013

2.  Reactive intermediates produced from the metabolism of the vanilloid ring of capsaicinoids by p450 enzymes.

Authors:  Christopher A Reilly; Fred Henion; Tim S Bugni; Manivannan Ethirajan; Chris Stockmann; Kartick C Pramanik; Sanjay K Srivastava; Garold S Yost
Journal:  Chem Res Toxicol       Date:  2012-11-06       Impact factor: 3.739

3.  Structure-activity relationship of capsaicin analogs and transient receptor potential vanilloid 1-mediated human lung epithelial cell toxicity.

Authors:  Karen C Thomas; Manivannan Ethirajan; Kiumars Shahrokh; Hao Sun; Jeewoo Lee; Thomas E Cheatham; Garold S Yost; Christopher A Reilly
Journal:  J Pharmacol Exp Ther       Date:  2011-02-22       Impact factor: 4.030

Review 4.  Metabolism of capsaicinoids by P450 enzymes: a review of recent findings on reaction mechanisms, bio-activation, and detoxification processes.

Authors:  Christopher A Reilly; Garold S Yost
Journal:  Drug Metab Rev       Date:  2006       Impact factor: 4.518

5.  Structural and enzymatic parameters that determine alkyl dehydrogenation/hydroxylation of capsaicinoids by cytochrome p450 enzymes.

Authors:  Christopher A Reilly; Garold S Yost
Journal:  Drug Metab Dispos       Date:  2005-01-07       Impact factor: 3.922

6.  Development and experimental application of an HPLC procedure for the determination of capsaicin and dihydrocapsaicin in serum samples from human subjects.

Authors:  Thomas Hartley; Brian Stevens; Kiran D K Ahuja; Madeleine J Ball
Journal:  Indian J Clin Biochem       Date:  2013-01-20

Review 7.  The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is not.

Authors:  Andrej A Romanovsky; Maria C Almeida; Andras Garami; Alexandre A Steiner; Mark H Norman; Shaun F Morrison; Kazuhiro Nakamura; Jeffrey J Burmeister; Tatiane B Nucci
Journal:  Pharmacol Rev       Date:  2009-09-11       Impact factor: 25.468

Review 8.  Bioavailability of capsaicin and its implications for drug delivery.

Authors:  William D Rollyson; Cody A Stover; Kathleen C Brown; Haley E Perry; Cathryn D Stevenson; Christopher A McNees; John G Ball; Monica A Valentovic; Piyali Dasgupta
Journal:  J Control Release       Date:  2014-10-12       Impact factor: 9.776

Review 9.  Fight fire with fire: Neurobiology of capsaicin-induced analgesia for chronic pain.

Authors:  Vipin Arora; James N Campbell; Man-Kyo Chung
Journal:  Pharmacol Ther       Date:  2020-11-10       Impact factor: 12.310

10.  Capsaicinoids, chloropicrin and sulfur mustard: possibilities for exposure biomarkers.

Authors:  Maija Pesonen; Kirsi Vähäkangas; Mia Halme; Paula Vanninen; Heikki Seulanto; Matti Hemmilä; Markku Pasanen; Tapio Kuitunen
Journal:  Front Pharmacol       Date:  2010-12-20       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.